Main Product Image

Olakin 150 Mg (Olaparib)

Subcategory: Cancer

Olakin 150 mg is a expression of Olaparib, a targeted anticancer medicine belonging to the PARP( Poly ADP- Ribose Polymerase) impediments class. It's primarily used in the treatment of different cancers of the ovary, bone, pancreas, and prostate due to BRCA1 or BRCA2 gene mutation. Olakin 150 mg is a tablet taken by mouth, and its targeted medium positions it as an essential option in perfection oncology. 
 
Composition and Packaging

 Each Olakin 150 mg tablet contains Olaparib 150 mg. The tablets are frequently film- carpeted and handed in bottles or fester strips, as the manufacturer's donation may vary. 
 
Mechanism of Action

 Olaparib works by precluding the PARP enzyme from performing, which is involved in repairing DNA damage in cells. In BRCA1 or BRCA2 mutant cancer cells, DNA form capability is formerly compromised. fresh PARP inhibition by Olaparib prevents DNA single- beachfront break form. This leads to the figure- up of damage, cell cycle arrest, and eventually, death in cancer cells. The particularity of killing only nasty cells makes Olakin an effective medicine that mildly impactsnon-cancerous cells to a lower extent. 
 
Indications

 Olakin 150 mg, also known as Olaparib, is used in the operation of numerous types of cancers but primarily those associated with BRCA mutations 
 
 Ovarian Cancer 
 
 conservation treatment of adult cases with platinum-sensitive regressed ovarian, fallopian tube, or primary peritoneal cancer. 
 
 First- line conservation of advanced BRCA- shifted ovarian cancer. 
 
Bone Cancer 
 
 In germline BRCA mutation- associated HER2-negative metastatic bone cancer. 
 
 Pancreatic Cancer 
 
 conservation remedy in metastatic pancreatic cancer with a BRCA mutation. 
 
 Prostate Cancer 
 
 In metastatic castration- resistant prostate cancer( mCRPC) in cases with specific homologous recombination form( HRR) gene mutations, including BRCA1/ 2. 
 
Dosage and Administration

 The typical grown-up cure of Olakin is 300 mg taken orally doubly diurnal (two 150 mg tablets per dose). still, the factual cure and duration may vary grounded on the cancer type, case’s response, renal function, and presence of side effects. The drug can be taken with or without food, but it should be swallowed whole and not crushed or masticated. 
 
Contraindications

 Olakin 150 mg is contraindicated in cases with history of acuity to Olaparib or any of the excipients.
 
 Severe hepatic or renal impairment without cure adaptation 
 
 Gestation( due to fetal damage) 
 
Warnings and Precautions

 Myelodysplastic Pattern( MDS) and Acute Myeloid Leukemia( AML) Though uncommon, disastrous bone gist diseases have been encountered. 
 
 Pneumonitis has passed in a limited number of cases. 
 
 Embryo- fetal toxin gestation is contradicted with Olakin. Non-childbearing ladies and males should be counseled to use effective contraception during and for 6 months after treatment. 
 
 Hematologic toxin Reduction in blood counts must be covered periodically due to the circumstance of anemia, neutropenia, and thrombocytopenia. 
 
Side Effects

 Common side effects of Olakin 150 mg are 
 
 Fatigue or weakness 
 
 Nausea and puking 
 
 Anemia 
 
 Diarrhea or constipation 
 
 Loss of appetite 
 
 Headache 
 
 Dizziness 
 
 Abdominal pain 
 
 All the side effects are manageable with probative remedy or adaptation of lozenge, but severe side effects should be reported to the doctor at formerly. 
 
Drug Interactions

 Olakin is subject to commerce with other drugs, particularly those that affect CYP3A enzymes in the liver. These include 
 
 Ketoconazole (potent CYP3A asset) and may increase situations of Olaparib 
 
 Rifampin( potent CYP3A debaser) and will drop its effect 
 
 All specifics, supplements, or herbal remedies a case is taking should be reported to their doctor. 
 
Storage

 Olakin 150 mg tablets should be stored at room temperature( 20 °C to 25 °C) in a dry place, not exposed to direct sun and humidity. Keep out of reach of children. 

Conclusion

 Olakin 150 mg( Olaparib) is a advance remedy in BRCA- shifted cancer remedy. Its capability to widely target cancer cells by inhibiting PARP has bettered recovery in numerous cases with ovarian, bone, pancreatic, and prostate cancers. still, like any cancer drug, it requires careful monitoring for side effects and medicine relations. In the hands of a medical expert, Olakin is a potent and tailored treatment of cancer. 

Messenger WhatsApp Call